根据亚表型和并发症指导的辅助色胺与标准单疗法在Staphylococcus aureus细菌病:两项随机试验的综合分析
Francesc Escrihuela-Vidal1,2,3, Julia García Larrauri1, Joaquín López-Contreras4,5,6
1Department of Infectious Diseases, Bellvitge University Hospital, L'Hospitalet de Llobregat, Barcelona, Spain.
The Lancet regional health. Europe
|March 6, 2026
概括
FEN-AUREUS分类有助于识别那些受益于组合治疗的黄金葡萄球菌菌血病 (SAB) 患者. 这种风险分层细化了治疗策略,以便在SAB患者中获得更好的结果.
科学领域:
- 传染性疾病 传染性疾病
- 临床微生物学 临床微生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 对 Staphylococcus aureus bacteriemia (SAB) 组合疗法的随机试验没有改善结果,这可能是由于缺乏针对风险的患者选择.
- 根据FEN-AUREUS分类系统,可以根据不同的临床亚现象类型进行早期风险分层.
研究的目的:
- 为了验证FEN-AUREUS分类框架在来自随机试验的组合患者队列中.
- 评估是否将FEN-AUREUS亚表型与IDSA定义的复杂SAB结合起来可以确定最有可能受益于辅助福米辛治疗的患者.
主要方法:
- 来自两个多中心随机试验的个体级数据的后期分析,评估SAB中的辅助色胺素.
- 用FEN-AUREUS框架将患者分为表型和风险亚表型.
- 评估了亚表型,复杂的细菌病和60天死亡率 (主要结果),30天死亡率和8周治疗成功率 (次要结果) 之间的关联.
主要成果:
- 高风险的FEN-AUREUS亚表型与60天死亡率的增加显著相关 (23.2%对6.6%),无论并发症状况如何.
- 将风险亚现象与IDSA分类结合起来,揭示了对辅助胺的异质反应.
- 在高风险,复杂的SAB患者中,辅助氏与显著更高的治疗成功率 (69.2%与25.8%相比;p=0.007) 以及降低死亡率的趋势有关.
结论:
- 将FEN-AUREUS风险亚表型与IDSA并发症标准相结合,可以精确识别可能受益于强化治疗的SAB患者.
- 这种分层方法支持在低风险患者中使用单疗法和个性化治疗策略,以改善结果.
- 在未来的临床试验和治疗指南中,FEN-AUREUS框架提供了一种完善患者选择的实用方法.
相关概念视频
Combined Effects of Drugs: Synergism
6.4K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.4K
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
260
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
260
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
386
Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
386
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
440
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
440
Acute Pyelonephritis II: Diagnostic Studies and Management
859
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
859
Clinical Significance of Antibiotic Resistance
106
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
106


